My PCR
Create Account
Logo PCR

21 May 2021

STEMIStents, scaffolds and DCB

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

Session comprising selected EuroPCR 2021 Hotlines & Late-Breaking Trials submissions

K. Kadota, G. Stefanini, J.M. Ten Berg

Summary

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary

Presentations available when logged in:

  • 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • A novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • Impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
Related Content
Large thrombus burden management in a young patient with inferior STEMI and multivessel disease From the legs to the coronaries: how Andreas Grüntzig reached his dream OCT- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial
Recommended for you
GulfPCR-GIM 2025 – What's on the Programme? OPTION-STEMI AICT-AsiaPCR: what's in store this year?